News | July 27, 2012

Accuray Rolls Out Comprehensive Customer Service Program in Japan

Company strengthens commitment to Japanese market, supporting growth of TomoTherapy system globally

July 27, 2012 — Accuray Inc. announced the extension of its Emerald Service Program for the TomoTherapy system, which provides equipment protection and product updates that improve clinical uptime and enhance technology utilization, to customers throughout Japan. As part of its ongoing commitment to strengthening customer service globally, Accuray will now interact directly with TomoTherapy customers in Japan to provide service programs in the Japanese radiation oncology market.

"We are dedicated to helping advance radiation oncology treatment in Japan, and this is a significant move toward ensuring that our current and future customers throughout the country benefit from the highest quality customer service," said Euan S. Thomson, Ph.D., president and CEO of Accuray. "We have seen clear traction for both the TomoTherapy and CyberKnife systems in Japan and believe that by managing the service program directly, we will be able to increase touch points with our customers, hear about their needs firsthand and reaffirm their confidence in our products."

The TomoTherapy system received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) in December 2004, and the first TomoTherapy system was installed in 2005. Presently there are 26 TomoTherapy systems and 25 CyberKnife robotic radiosurgery systems in use in Japan.

Previously, Hitachi Medical Corp. provided service and support for TomoTherapy customers in Japan. With the rollout of the Emerald Service Program, Hitachi Medical will transfer the regulatory approval and service business to Accuray. The move to take service in-house provides new opportunities for growth and further market penetration for both the CyberKnife and TomoTherapy systems in Japan. Accuray forecasts that the transfer of the service business from Hitachi Medical to Accuray will drive an increase in service revenue.

Accuray and Hitachi Medical will continue to partner on sales and distribution, enabling Accuray to benefit from Hitachi Medical's deep territory penetration in the Japan's radiation oncology market. Accuray expects the relationship to also provide opportunities for future growth of the TomoTherapy business globally.

For more information: www.accuray.com

Related Content

Sponsored Content | Videos | Radiation Therapy | January 18, 2019
Join Chris Toth, president of Varian’s Oncology Systems business, for a look at product introductions for 2018 plus
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.